Abstract: Dimethyl dioctadecyl ammonium bromide (DDA), a lipophilic quaternary amine, was evaluated in adult chickens for potentiation of immunological responses to subcutaneously administered inactivated Newcastle disease virus (NDV) vaccines. DDA enhanced humoral and cell-mediated immune (CMI) responses to levels which were significantly higher than those induced by the vaccine alone The haemagglutination inhibition antibody titers induced by DDA were slightly lower than those induced by mineral oil although neutralizing antibody titers seemed to be higher. DDA induced strong CMI (DTH and lymphocyte proliferation) responses, more than those induced by Freund's complete adjuvant and mineral oil. Both DDA and mineral oil induced comparable high levels of protection to challenge doses of 200000 LDs0 per chicken. No toxic effects or local tissue damage were observed in any of the inoculated chickens.
Introduction
Immunological adjuvants are of major importance as agents for potentiation of the immune response to inactivated viral vaccines. Out of the many experimental adjuvants, only mineral salt adjuvants are licensed for human use and only two additional adjuvants, mineral oil and saponin (or its purified derivative, Quil A), are licensed for veterinary use. However, these adjuvants are not entirely without side effects and only partially effective for certain viral diseases [1] [2] [3] [4] [5] [6] . The qua-ternary ammonium lipoid compound, dimethyl dioctadecyl ammonium bromide (DDA) is one of the many synthetic materials with adjuvant activity which was discovered and studied as part of the effort for finding new, safe and effective immunostimulators [7] [8] [9] .
In a previous study [10] , we compared, in mice, the immunopotentiating properties of DDA to that of two other well-known adjuvants, Freund's complete adjuvant (FCA) and aluminium hydroxide. The study, in which inactivated Semliki Forest virus (SFV) served as the immunogen, indicated the superiority of DDA in inducing delayed-type hyersensitivity (DTH). DDA enhanced humoral antibodies also but to a similar extent as FCA and aluminium hydroxide. However, it had a typical effect on IgG-isotype switching: it induced a high proportion of IgG2a and IgG2b antibodies and low proportions of IgG1 antibodies. This antibody isotype pattern was similar to the pattern induced by FCA and different from that induced by aluminium hydroxide or by the antigen alone.
In this study, the efficacy of DDA as an adjuvant in chickens for inactivated Newcastle disease virus (NDV) vaccines was tested. This experimental system, which was used before in a short study by Ruke et al. [11] , is as close as possible to real field conditions since NDV is also causing a severe disease in chickens and is of great concern for the poultry industry all over the world.
There are numerous commercial NDV vaccines, live and inactivated, which perform satisfactorily in the control of the disease in nature. Live attenuated vaccines are administered mainly to young chicks while inactivated vaccines are used mainly for laying hens. Most of the inactivated NDV vaccines are adjuvanted by mineral oil which are effective but do produce local reactions at the site of inoculation [12] .
The adjuvant effects of DDA, FCA and mineral oil were compared in chickens which were inoculated subcutaneously in combination with inactivated NDV. Immunity was evaluated by determination of antibody response, DTH, lymphocyte proliferation and resistance to challenge with virulent NDV.
Materials and Methods

Virus
NDV (strain Komarov II) was propagated in Specific Pathogen Free (SPF) 10-day-old, embryonated eggs. Each egg was inoculated into the allantoic cavity with 0.1 ml from a 1:1000 dilution of the seed virus by standard procedures [13] . Eggs containing dead embryosl after 24 h, were discarded. Live embryos were further incubated (37°C) for three days. At the end of the incubation, the eggs were cooled for a few hours at 4°C. The allantoic fluids were harvested individually from each egg and monitored for NDV activity by a qualitative haemagglutination slide test. Haemagglutinin (HA) positive fluids were pooled, clarified by centrifugation (2000 rpm for l0 rain) and stored at -70°C until used. These NDV stocks, thus prepared, were titrated in embryonated eggs by the allantoic route of inoculation. Ten-fold dilutions (10-5-10-10) were prepared in phospate buffered saline (PBS), inoculated into 9-10-dayold embryonated eggs and incubated at 37°C for 72 h. Five eggs were used for each dilution. At the end of the incubation, small samples of the allantoic fluids were withdrawn and tested for HA (slide test). The 50% egg infective dose (EIDs0) was determined by the Reed-Muench method [13] .
For inactivation, part of the NDV stock was treated by /3-propiolactone as previously described [10] . The virus was centrifuged in a Beckman ultracentrifuge at 90 000 × g for 100 rain and resuspended in PBS to one tenth of its original volume. Samples of the concentrated NDV preparations were tested in embryonated eggs for residual live NDV. Inactivation was considered successful when no residual viral infectivity was found. The inactivated antigen preparations were stored in -70°C until used.
A portion of the virus stock was further purified by ultracentrifugation (Beckman, Palo Alto, USA) on a 5%-50% sucrose gradient, in a SW-28 rotor, for 60 rain at 90000×g [14] . Fractions, with the majority of HA activity, were pooled and centrifuged in a R-65 rotor, at 100000 ×g for 90 min. The pellet was resuspended in PBS to one seventh of the original volume.
NDV haemagglutinins were titrated in 0.05 ml quantities, in a micro-hemagglutination test, performed in round-bottom 96-well microplates, with 0.75% chick red blood cells (ChRBC). The titre (number of HA units per 0.05 ml) was defined as the reciprocal of the last test dilution that still demonstrated haemagglutination [13] .
Estimation of the relative purity of viral preparations
The relative purity (RP) of viral preparations, expressed as HA mg-~ protein, was estimated by dividing the number of HA units per ml to the protein concentration (rag ml-~).
Protein concentrations were determined by Bradford's method [15] , in comparison to a bovine serum albumin (BSA) standard.
Virus-adjuvant mixtures
DDA (Eastman Kodak, USA) was prepared by suspension of the powder in sterile-pyrogen free physiological saline (Travenol, Israel). A fine homogenous dispersion of the powder was obtained by heating the suspension to 60°C for 15-20 min. After cooling at room temperature the DDA suspension was mixed with an equal volume of the inactivated NDV (diluted in saline) and rocked for 20-60 min at room temperature. The concentration of DDA used for each experiment will be recorded below in Results. FCA (Difco, USA) was emulsified with an equal volume of the inactivated virus suspension (in saline) by vigorous mixing on a vortex mixer. Emulsions in mineral oil were prepared in a similar way.
Immunization of chickens
For determination of humoral antibodies and resistance to challenge, White Leghorn roosters were reared at the veterinary institute (BetDagan). At the age of 5 weeks they were vaccinated subcutaneously with 0.5 ml of inactivated experimental NDV vaccines or with commercial vaccines. The amount of virus per dose in the experimental vaccine which was prepared from the concentrated stock (RP = 400000 HA ml -l) 305 was 500 HA units which is equivalent to 4.5 x 108 EIDs0 before inactivation. Commercial vaccines contained approximately the same amount of virus per dose.
For determination of delayed-type hypersensitivity White Leghorn roosters were reared at the Faculty of Agriculture in Rehovot, first up to the age of 4 weeks in an electrically heated battery and then in separate cells in regular batteries. For performance of the lymphocyte proliferation assay, roosters were reared up to the age of 5 weeks under sterile conditions in isolator units. Before the beginning of the experiments they were transferred to regular batteries.
All chickens were wing-banded and bled before vaccination. They were kept in pairs and fed on commercial feed and water ad libitum.
Evaluation of humoral immunity
Antibody determination by the haemagglutination inhibition test. The haemaglutination inhibition (HI) test was performed essentially as described elsewhere [16] . Briefly, 0.05 ml of two-fold dilutions of sera in PBS were prepared in Ushaped, 96-well microtitre plates (Dynatech, USA). To each of the wells, 0.05 ml of 4 HA units of NDV were added and incubated for 20 min at RT. Chicken red blood cells (0.75% in PBS) were added, and incubated at 4°C for 60-90 min. The reciprocal of the last serum dilution showing an inhibition of haemagglutination was considered as the HI antibody titre of the serum.
Determination of neutralizing antibodies by the haemadsorption inhibition test.
The haemadsorption inhibition (HAdI) test was performed in chick embryo fibroblasts, in microplates as described elsewhere [17] . First, the titre of the virus was determined in HAd units. For titration of HAdI antibodies (neutralizing antibodies) two-fold dilutions of chicken sera were prepared in PBS and incubated for 45 min at 37°C with 100 HAd units of NDV. Cells, at a concentration of 1-1 × 10 6 0.05 ml per well, were added and incubated for 48 h at 37°C. Chicken red blood cells (0.75% in PBS) were added for 1 h at 4°C. The reciprocal of the last serum dilution showing an inhibition of haemadsorption was considered as the HAdI antibody titre of the serum.
Evaluation of cellular immunity
Induction and evaluation of delayed-type hypersensitivity. Delayed-type hypersensitivity (DTH) in immunized roosters was measured as described by Hudson and Hay [18] . Groups of roosters, at the age of 7-12 weeks, were inoculated subcutaneously with different compositions of adjuvants and NDV. Ten days later, roosters were inoculated into the right wattle with 101° EIDs0 of NDV and into the left one with saline. Thickening of wattles was measured with calipers (accuracy = 0.01 cm) 24 h after inoculation or later. At the end of the experiment the width difference between the right and the left wattle for each rooster was calculated.
The lymphocyte proliferation assay. The lymphocyte proliferation assay was performed essentially as described by Timms [19] . Groups of roosters at the age of 5 weeks were first inoculated subcutaneously with combinations of adjuvants and inactivated NDV and boosted later with inactivated NDV alone. The precise schedule will be described in the Results section. Heparinated blood (5-10 ml) was taken from each bird, and centrifuged at 50 x g for 13 min. Lymphocytes, derived from the upper layer, were washed in RPMI-1640 supplemented with Lglutamin and antibiotics (1 in 100 dilution of penicillin and streptomycin, Beit-Haemek, Israel), counted and distributed, 2× 106/well, to microplates (Nunc, Denmark). Peripheral blood lymphocytes from immunized and control chickens were stimulated in vitro in triplicate with: (1) medium alone, (2) inactivated NDV, (3) purified protein derivative (PPD) and (4) concanavaline A (ConA). NDV and PPD were used at different concentrations, and ConA was used at a concentration of 20 /xg ml 1. Plates were incubated at 39°C, in a gas atmosphere of 5% CO 2 and 80% humidity for 48 or 72 h. Twenty /xl of 1 ~zCi of 3H-thymidine were added to each well. After 18 h, cells were harvested in a cell harvester (Dynatec, USA) and transferred to vials containing scintillation fluid for radioactivity measurements in a Beckman LS 7800 counter Stimulation indices (SI), representing the degree of thymidine incorporation and lymphocyte proliferation, were calculated by dividing the radioactive counts obtained from wells containing antigens or nonspecific stimulators by the counts of the nonstimulated (medium containing) control wells.
Resistance to challenge
Chickens, 3 to 4 weeks after immunization, were transferred for challenge to a special isolation unit of the Veterinary Institute. Each chicken received, intramuscularly, 200000 LDs0 of an Israeli velogenic strain. Mortality was recorded daily for 3 weeks after infection.
Statistical analysis
ELISA or DTH results were expressed as average values +_ standard error. The statistical significance of differences between means was determined by Student's t-test. In challenge experiments the chi-square test was used for the determination of statistical significance between groups. 
Results
Characterization of virus preparations
NDV (Komarov strain) was grown in embryonated eggs, harvested from the allantoic fluid and inactivated by/3-propiolactone. Virus stocks were purified and concentrated by ultracentrifugation and sucrose density-gradient centrifugation. The virus content and relative purity of each of the preparations were tested and summarized in Table 1 .
Effect of adjuvants on resistance to NDV challenge and antibody response to NDV after one single inoculation of vaccines
Experiments were performed to study the adjuvant effect of DDA in inactivated NDV vaccines on resistance to NDV challenge and on the antibody response.
In one experiment, groups of chickens were inoculated with the inactivated NDV preparation without additives and with preparations containing mineral oil and different amounts of DDA. Each chicken received 500 HA units per dose which were obtained by dilution of the concentrated stock preparation (RP = 12500 HA mg-1) in saline. In addition, one group was inoculated with the commercial mineral oil-based vaccine of MABAT and another group was kept untreated. Each group consisted of 10 chickens, except for 307 the last group (the untreated) which consisted of 20 chickens. Chickens were bled on the day of vaccination (day 0) and 20 days later for determination of HI antibodies. Nine days after the last bleeding they were challenged with virulent NDV. No antibodies were found in sera from day 0. Results of HI antibodies in serum from blood drawn 20 days after vaccination and of survival rates after challenge are summarized in Table 2 . The adjuvant effect of DDA (groups 1-4) after a single inoculation is, in general, similar to the effect of mineral oil (group 6). The commercial vaccine (MABAT) induced more antibodies than any other vaccine. All adjuvant preparations (DDA or mineral oil) induced statistically significant more antibodies than group 5 (NDV without adjuvant). Survival rates were also significantly higher in the groups injected with the adjuvant containing vaccines. The individual survival rates of these groups (70-90%) were not statistically different.
The aim of the second experiment was designed to study the effect of the relative purity of the NDV antigen on the adjuvanticity of DDA. NDV preparations with different relative purities were obtained by addition of appropriate amounts of allantoic fluid and saline to the concentrated NDV preparation. The final concentration of NDV in each preparation was equal (500 HA units per dose). Fifteen groups of chickens were Table 2 The adjuvant effects of DDA and mineral oil in inactivated NDV vaccines on resistance to virulent NDV challenge and on antibody response in vaccinated chickens Table 3 . Groups 1 to 4 were injected with 0.5 mg DDA per dose (1.0 mg ml -t) mixed with 4 NDV preparations, each with a different relative purity. The same 4 different NDV preparations were injected to groups 5 to 8 but with a DDA concentration of 4.0 mg ml-1 (2.0 mg per dose); Groups 9 and 10 were inoculated with only two NDV preparations (RP = 12500 HA mg -1 and RP=400000 HA mg -~) each mixed with 16.0 mg ml-~ of DDA (8.0 mg per dose). The 5 remaining groups served as controls: group 11 was injected with the commercial vaccine (MABAT), group 12 with NDV in saline (RP = 400000 HA mg-1), group 13 with NDV in allantoic fluid (RP = 12500 HA mg -1) group 14 with allantoic fluid without virus and group 15 was left untreated. Chickens were bled on day 0 and 21 for determination of HI antibodies. One week after the last bleeding they were challenged with virulent NDV. No antibodies were found in day 0 sera. Results of HI antibodies (all groups) and neutralizing (HAdI) antibodies (groups 9 to 15 only) in day 21 sera, and of survival rates after challenge are summarized in Table 3 .
The adjuvanticity of DDA is confirmed once again in this experiment since both antibody response and resistance to challenge were significantly higher in the groups of chickens which were vaccinated with DDA-containing vaccines (groups 1 to 10) than in the chickens which were inoculated with the inactivated virus without adjuvants (groups 12 and 13). DDA also induced relatively high levels of neutralizing antibodies (groups 9 and 10). The relative purity of the DDA-containing vaccines did not affect significantly the HI antibody response, the neutralizing antibody level (HAdI) and resistance to challenge.
The effect of adjuvants on the cellular immune response
Cellular immunity was tested in vaccinated chickens by two techniques, one for determina- Table 3 The effect of preparations the relative purity of NDV on antibody response and immunity in chickens vaccinated with DDA-containing tion of DTH and the second for determination of lymphocyte proliferation.
The effect of adjuvants on the DTH responses in uaccinated chickens.
The optimal time for measuring DTH in the wattles of vaccinated chickens was determined in two groups of 5 chickens. One group was inoculated with an emulsion of inactivated NDV and FCA and the second with a mixture of inactivated NDV and DDA. Two weeks after vaccination stimulation was performed by inoculating the right wattle with inactivated NDV and the left wattle with saline. The widths of the wattles were measured 24, 48 and 96 h after stimulation (Table 4 ). Significant differences (P < 0.05) between the right and left wattles were observed only 24 h after stimulation which indicated that the optimal time for measuring DTH responses in vaccinated chickens was 24 h after an intradermal inoculation of the stimulating antigen into the wattles.
In a second experiment chickens were induced for DTH responses at different times after vaccination (7, 14 and 28 days) with mixtures of NDV and DDA. Twenty-four hours after inoculation of right wattles with antigen and left wattles with saline, widths of wattles were measured and the differences between the right and left wattles were calculated. A fourth control group of chickens was not vaccinated but was stimulated by inoculation of right (NDV) and left (saline) wattles 14 days after the onset of the experiment. Results, summarized in Table 5 , indicate that within the period of about 1 to 3 weeks after vaccination, similar DTH responses were obtained in all 3 groups of vaccinated chickens and that the average width differences induced in the wattles were significantly higher than the one induced in the control group.
The influence of adjuvants on the DTH response in vaccinated chickens was compared in 6 groups of chickens as outlined in Fig. 1 . Three groups of chickens were used for comparison of three adjuvants, mineral oil (in the commercial vaccine of MABAT), DDA and FCA. The other three groups served as controls, one for the effect of DDA alone, the second for the effect of inactivated NDV without additives and the third which was inoculated with saline only. Eight days after vaccination, chickens were tested for specific DTH responses to NDV. All adjuvants induced Table 5 DTH at different times after vaccination of chickens with an NDV vaccine containing 4.0 mg ml-1 DDA. Widths of wattles were measured at 24 h after inoculation with inactivated NDV ). The other three groups which served as controls were inoculated with DDA alone, with NDV without additives and with saline. The number of chickens per group (n) is indicated. Eight days after vaccination, chickens were tested for specific DTH responses to NDV expressed as the width differences of right and left wattles+S.E. The letters on the columns indicate significance groups which are statistically different using the t-test (P < 0.05).
DTH responses which were higher than that induced by the virus alone. DDA induced the highest DTH response, FCA an intermediate response and mineral oil the lowest response (Fig. 1) .
The effect of adjuvants on the lymphocyte proliferation assay in vaccinated chickens. The aim of the first experiment was to determine optimal conditions for stimulation of peripheral blood lymphocytes from NDV vaccinated chickens with inactivated NDV antigen preparations. Out of a total of six (5-weeks-old) chickens, 2 were inoculated subcutaneously with saline, 2 with inactivated NDV (500 HA/dose) and 2 with a mixture of NDV and DDA (500 HA of NDV and 2 mg of DDA/dose). Each chicken received 2 more injections at 14 day intervals. Blood was tested by the lymphocyte proliferation assay at 10 days after each inoculation. Half of the cultures were stimulated after 48 h and the other half after 72 h, for comparison. All lymphocyte preparations were stimulated with ConA (20 Izg ml -]) and with 4 concentrations of the purified NDV (250, 500, 1000 and 2000 HA units); results are summarized in Table 6 . Since lower SI values were obtained with 250 and 2000 HA units of NDV, they were omitted from the table. Also, only results which were obtained after the third inoculation of the chickens are shown, since no proliferation of lymphocytes was obtained after the first or the second injections. From this experiment it is evident that optimal conditions for stimulation of lymphocytes were obtained in 48 h cultures with both ConA and the NDV antigen. The optimal concentration of the NDV preparation for stimulation was 500 HA units.
In another experiment we compared the effect of 3 adjuvants, DDA, FCA and mineral oil (MABAT) which were incorporated in 3 inactivated NDV vaccines, on the lymphocyte proliferation assay. In addition, two control groups of chickens were included, one of which was inoculated with saline and another which was inoculated with inactivated NDV without adjuvants. The amount of NDV in the FCA-and DDA-containing vaccines was 500 HA units per dose. The Table 6 Determination of optimal conditions for lymphocyte proliferation assays with peripheral concentration of DDA (in the NDV + DDA vaccine) was 4.0 mg m1-1 (2 mg/dose). The four groups of chickens which were inoculated with NDV received a booster injection 10 days later which consisted of 500 HA units of inactivated virus (without adjuvants). Chickens were bled at the day of booster and 8 days later and tested for HI antibodies and for cellular immunity by the lymphocyte proliferation assay. Lymphocytes were stimulated with PPD (50 /xg ml -]) and with 500 HA units of gradient purified NDV. Significant stimulation values were obtained only after the second injection. Results are summarized in Fig.  2A (stimulation with NDV) and Fig. 2B (stimulation with PPD). HI values for each group of chickens are also shown for comparison ( Fig. 2A) .
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Discussion
The adjuvant activity of DDA is already well established. However, different results were obtained with different experimental systems. In some systems it induced only cell-mediated immunity in the absence of antibodies and in other systems it enhanced antibody production [8, 9] :
In the present study, one single inoculation of the inactivated NDV-DDA mixtures in chickens induced enhanced responses of antibodies, cellmediated immunity and protection to challenge. In one experiment (Table 2) The four groups of chickens that were inoculated with NDV received a booster injection ten days later which consisted of 500 HA units of inactivated virus (without adjuvants). Results are from blood taken (from all groups) 8 days after the booster injection. In (A) lymphocyte cultures were stimulated with purified NDV antigen (500 HA), and in (B) with PPD (50 /xg ml-1). Bars indicate standard errors. HI antibody titres, expressed as Log 2, are also shown (A). Other symbols are as described in Fig. 1 .
the commercial mineral oil vaccine, was obtained with the 8.0 mg/dose in another experiment ( Table 3 ). In general, on the basis of all experiments (Tables 2 and 3 ), higher levels of HI antibodies were obtained with the commercial mineral oil vaccine than with most of the DDA-containing preparations. DDA, however, induced high levels of neutralizing antibodies (HAdI) to NDV, higher than those induced by the antigen alone or by the commercial mineral oil vaccine (Table 3 ). It seems therefore that DDA has a differential influence on the type of antibodies to be produced. Since this finding is based on the results of one experiment, we regard it as a preliminary finding that should be confirmed by more experiments in the future. In all our experiments (Tables 2 and 3 ) DDA induced an excellent immunological resistance to a high dose challenge of virulent NDV (200000 LDs0) which was comparable to the resistance induced by the commercial mineral oil vaccine. This resistance also seemed to be dose-independent, at least within the range of DDA concentrations tested. It is possible that, in order to see a clear dose-dependence, lower doses of DDA should have been used. A hint for this can be found in the experiment of Ruke et al. [11] who obtained a lower survival rate with a dose of 0.1 mg (53%) than with 0.5 mg and 2.5 mg (67 and 73%, respectively).
As already discussed in our previous paper [10] there is no agreement as to the exact mechanism of action of DDA. One group of authors mantains that the adjuvanticity of DDA is independent of the presence of antigen [20] [21] [22] [23] while others have shown the importance of direct binding of the antigen to DDA or simultaneous addition of the DDA and antigen at the same inoculation site [24] [25] [26] . In the present study, DDA vaccines which contained NDV antigen preparations of different purities were compared ( Table  3 ). Assuming that binding of DDA to the antigen is important for its adjuvant activity, we believed that purified antigen preparations will interact more efficiently with DDA than crude preparations and therefore will elicit a better immune response. Surprisingly, the relative purity of the NDV antigen in the DDA containing vaccines had no effect on the nature or intensity of the immune response. We have no clear-cut explanation for this result. It could be that the impurities of the allantoic fluid interfere with the binding of the NDV antigen to DDA but binding is not a prerequisite for its adjuvant activity or, alternatively, binding of DDA to the antigen is essential for adjuvanticity yet DDA has the capacity to adsorb the NDV antigen in the presence of impurities.
DDA had a substantial influence on enhancing DTH (Fig. 1 ) and lymphocyte proliferation (Fig.  2) responses to NDV antigens in chickens which were vaccinated with NDV-DDA mixtures. The degree of responses with DDA-containing vaccines was significantly higher than with vaccines adjuvanted by FCA or mineral oil. These results, which are in agreement with other authors, confirm once more the efficacy of DDA as an immunopotentiator of the cellular arm of the immune system. However, this capacity of DDA is most probably not universal since DDA was less effective in enhancing immunity to non-enveloped viruses like encephalomyocarditis virus [27] and foot and mouth disease [28] . In view of the possible mechanisms of action of DDA it seems that immunopotentiation is dependent on the nature of the antigen which presumably dictates the correct physicochemical interaction with the adjuvant and the most efficient configuration for presentation to the immune system. It might be very interesting to find the general rule for this interaction. This will enable exploitation of this remarkable adjuvant effect of DDA for a broader spectrum of antigens.
This study has proven the efficacy of DDA as an adjuvant for improving the immune response to inactivated NDV vaccines in chickens. As previously reported for mice [10] , we have not observed any undesirable, general or local, side effects in chickens inoculated subcutaneously with the DDA-containing vaccines.
